Hypertensive patients with false-positive Thallium-201 scintigraphic results in the infero-posterior wall are in high risk for coronary artery disease development

International Journal of Cardiology

Volumn 117, Issue 2, 2007, Pages 178-183

  Michaelides, Andreas P ^a   Tousoulis, Dimitrios ^a   Fourlas, Christos A ^a   Vyssoulis, Gregory P ^a   Andrikopoulos, George K ^a   Aznaouridis, Konstantinos A ^a   Stefanadis, Christodoulos I ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Arterial hypertension; Coronary artery disease; Infero posterior reversible perfusion defect; Thallium 201 scintigraphy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; THALLIUM 201;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; COLLIMATOR; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART VENTRICLE WALL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SCINTIGRAPHY; THORAX PAIN;

ADULT; CHEST PAIN; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; ECHOCARDIOGRAPHY; EXERCISE TEST; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; RADIONUCLIDE VENTRICULOGRAPHY; RISK FACTORS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33947386689     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.06.011     Document Type: Article

References (18)

1. Schulman D.S., Francis C.K., Black H.R., and Wackers F.J. Thallium-201 stress imaging in hypertensive patients. Hypertension 10 (1987) 16-21
2. DePuey E.G., Guertler-Krawczynska E., Perkins J.V., Robbins W.L., Whelchel J.D., and Clements S.D. Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography. Am J Cardiol 62 (1988) 234-238
3. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-46.
4. Garcia E., Van Train K., Maddahi J., et al. Quantification of rotational thallium-201 myocardial tomography. J Nucl Med 26 (1985) 17-26
5. Klocke F.J., Baird M.G., Lorell B.H., et al. American College of Cardiology; American Heart Association; American Society for Nuclear Cardiology. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). American College of Cardiology Web site. Available at: http://www.acc.org/clinical/guidelines/radio/index.pdf, 2003. Accessed August 18, 2003.
6. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations, for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
7. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
8. Du Bois D., and Du Bois E.F. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5 5 (Sep-Oct 1989) 303-311
9. Vourvouri E.C., Poldermans D., Schinkel A.F., et al. Left ventricular hypertrophy screening using a hand-held ultrasound device. Eur Heart J 23 (2002) 1516-1521
10. Chin W.L., O'Kelly B., Tubau J.F., et al. Diagnostic accuracy of exercise thallium-201 scintigraphy in men with asymptomatic essential hypertension. Am J Hypertens 5 (1992) 465-472
11. Prisant L.M., von Dohlen T.W., Houghton J.L., Carr A.A., and Frank M.J. A negative thallium (±dipyridamole) stress test excludes significant obstructive epicardial coronary artery disease in hypertensive patients. Am J Hypertens 5 (1992) 71-75
12. Cecil M.P., Pilcher W.C., Eisner R.L., Chu T.H., Merlino J.D., and Patterson R.E. Absence of defects in SPECT thallium-201 myocardial images in patients with systemic hypertension and left ventricular hypertrophy. Am J Cardiol 74 (1994) 43-46
13. Houghton J.L., Frank M.J., Carr A.A., von Dohlen T.W., and Prisant L.M. Relation among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 15 (1990) 43-51
14. Houghton J.L., Carr A.A., Prisant L.M., et al. Morphologic, hemodynamic and coronary perfusion characteristics in severe left ventricular hypertrophy secondary to systemic hypertension and evidence for nonatherosclerotic myocardial ischemia. Am J Cardiol 69 (1992) 219-224
15. Iriarte M., Caso R., Murga N., et al. Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of thallium-201 scintigraphy. Am J Cardiol 75 (1995) 335-339
16. Tubau J.F., Szlachcic J., Hollenberg M., and Massie B.M. Usefulness of thallium-201 scintigraphy in predicting the development of angina pectoris in hypertensive patients with left ventricular hypertrophy. Am J Cardiol 64 (1989) 45-49
17. Blumenthal R.S., Becker D.M., Moy T.F., Coresh J., Wilder L.B., and Becker L.C. Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population. Circulation 93 (1996) 915-923
18. Fleg J.L., Gerstenblith G., Zonderman A.B., et al. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation 81 (1990) 428-436